39 
MR. HUTT: Thank you. 
DR. FREDRICKSON: Are there other questions or comments for Ms. Simring? 
If not, thank you very much, Ms. Simring. 
We move now to discussion of the matter of physical containment, the 
next stage down the path of the published proposed revisions. 
DR. WRIGHT: Excuse me, Dr. Fredrickson, some of us would like to 
make comments. 
DR. FREDRICKSON: I am sorry, would you identify yourself? You are 
Susan Wright? 
gan. 
DR. 
DR. 
DR. 
we would 
DR. 
King 
DR. 
and 
DR. WRIGHT: Assistant Professor Wright, of the University of Michi- 
DR. FREDRICKSON: The University of Michigan, yes. 
DR. SHAW: We can't hear you. 
introduction, and we would like to do that if possible. 
DR. MC CARTHY : It was my understanding that Dr. King wanted to talk 
on physical containment, but if you prefer now I have no objections. 
DR. KING: It would probably be more appropriate to talk about the 
introduct ion . 
DR. CHILTON: I have comments also on the introduction. 
DR. FREDRICKSON: Fine. Do you prefer to appear now, Dr. King? 
DR. KING: Yes. 
DR. FREDRICKSON: All right, we will continue on this matter of the 
introduction, the public witnesses. This is Dr. Jonathan King from MIT. 
DR. KING: I am pleased to have the opportunity to address these 
hearings. I am kind of substituting for Richard Goldstein of Harvard, who 
couldn ' t make it . 
The Recombinant DNA Program Committee and the Recombinant DNA Office 
have worked long and hard, often buffeted by pressures from many direc- 
tions. Their work has been difficult and demanding, and they deserve our 
[ 243 ] 
